Walleye Trading
RARE icon

Walleye Trading’s Ultragenyx Pharmaceutical RARE Stock Holding History

Walleye Trading’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,800
Closed -$142K – 4376
2026
Q1 		$142K Sell
6,800
-4,300
-39% -$96.8K ﹤0.01% 3299
2025
Q4 		$255K Sell
11,100
-3,700
-25% -$122K ﹤0.01% 3256
2025
Q3 		$445K Buy
14,800
+11,400
+335% +$342K ﹤0.01% 2811
2025
Q2 		$124K Buy
+3,400
New +$123K ﹤0.01% 3493
2024
Q1 		– Sell
-3,800
Closed -$182K – 5231
2023
Q4 		$182K Sell
3,800
-4,200
-53% -$163K ﹤0.01% 3840
2023
Q3 		$285K Buy
8,000
+5,000
+167% +$198K ﹤0.01% 3393
2023
Q2 		$138K Buy
+3,000
New +$139K ﹤0.01% 3608
2023
Q1 		– Sell
-1,200
Closed -$55.6K – 5295
2022
Q4 		$55.6K Buy
+1,200
New +$47.2K ﹤0.01% 4180
2022
Q3 		– Sell
-20,000
Closed -$1.19M – 5436
2022
Q2 		$1.19M Sell
20,000
-24,100
-55% -$1.48M ﹤0.01% 2064
2022
Q1 		$3.2M Buy
44,100
+21,700
+97% +$1.51M 0.01% 1300
2021
Q4 		$1.88M Buy
+22,400
New +$1.82M 0.01% 1694
2021
Q2 		– Sell
-2,500
Closed -$285K – 5474
2021
Q1 		$285K Buy
2,500
+1,700
+213% +$231K ﹤0.01% 3275
2020
Q4 		$111K Buy
+800
New +$94.9K ﹤0.01% 3882

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Walleye Trading's RARE Position: Q2 2026 in Review

Walleye Trading sold out of Ultragenyx Pharmaceutical (RARE) in Q2 2026, closing a stake of 7,039 shares — an estimated $147K sold.

Walleye Trading first reported a position in RARE in Q3 2015 and held it in 13 quarters. The position peaked at $2.06M in Q4 2020. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Walleye Trading reported no remaining Ultragenyx Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 7,039 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $147K.
  • Walleye Trading first reported a position in Ultragenyx Pharmaceutical in Q3 2015 and held it in 13 quarters.
  • Walleye Trading's Ultragenyx Pharmaceutical position peaked at $2.06M in Q4 2020.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.